Yandex NV (NASDAQ: YNDX) has reported E.P.S. of $-0.58 for its fourth fiscal quarter (ending December 31) versus $-0.12 for the same period a year ago — an increase of 383%. E.P.S. were $-1.68 for […]
For its fourth fiscal quarter (ending December 31), Travere Therapeutics Inc (NASDAQ: TVTX) has reported a -37% decline in E.P.S. from $-1.16 a year ago to $-0.73 in the current quarter. E.P.S. were $-4.06 for […]
On 2/20/25, Shenandoah Telecommunications Co (NASDAQ: SHEN) stock suffered a major decline of -10.2%, closing at $10.62. Moreover, this decline was accompanied by exceptionally high trading volume at 267% of normal. Relative to the market […]
On 2/20/25, Sabre Corp (NASDAQ: SABR) stock enjoyed a major increase of 22.4%, closing at $4.15. Moreover, exceptionally high trading volume at 333% of normal accompanied the advance. The stock has been strong relative to […]
On 2/20/25, Pediatrix Medical Group Inc (NYSE: MD) stock enjoyed a major increase of 22.1%, closing at $17.23. Moreover, exceptionally high trading volume at 319% of normal accompanied the advance. Relative to the market the […]
Olympic Steel Inc (NASDAQ: ZEUS) has reported E.P.S. of $0.33 for its fourth fiscal quarter (ending December 31) versus $0.64 for the same period a year ago — a decline of -48%. For the latest […]
Freshpet Inc (NASDAQ: FRPT) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.37 versus $0.32 for the same period a year ago — an increase of 16%. E.P.S. were $0.97 for […]
Evolent Health Inc (NYSE: EVH) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.27 versus a loss $-0.36 for the same period a year ago — a decline of -25%. […]
For its fourth fiscal quarter (ending December 31), DigitalBridge Group Inc (NYSE: DBRG) has reported a -118% decline in E.P.S. from $0.67 a year ago to $-0.12 in the current quarter. For the latest four […]
On 2/20/25, DRDGold Ltd (NYSE: DRD) stock enjoyed a major increase of 10.3%, closing at $11.64. Moreover, exceptionally high trading volume at 232% of normal accompanied the advance. Relative to the market the stock has […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research